Watkins_1999_Pharmacol.Biochem.Behav_62_743

Reference

Title : Blockade of nicotine self-administration with nicotinic antagonists in rats - Watkins_1999_Pharmacol.Biochem.Behav_62_743
Author(s) : Watkins SS , Epping-Jordan MP , Koob GF , Markou A
Ref : Pharmacol Biochem Behav , 62 :743 , 1999
Abstract :

The reinforcing properties of a variety of drugs abused by humans have been investigated using the technique of intravenous self-administration in the rat. To examine the effect of nicotine dose on nicotine self-administration, Wistar rats were allowed to self-administer various doses of nicotine using a within-subjects Latin square design. An inverted U-shaped dose response curve was obtained, with the highest rates of responding at the 0.03 mg/kg/inf dose. With 1-h daily nicotine self-administration sessions, rats did not appear dependent on nicotine 24 h later, as indicated by the absence of somatic signs of withdrawal after subcutaneous injection of a nicotinic acetylcholine receptor antagonist, mecamylamine (0.57 mg/kg). In another set of studies, pretreatment with subcutaneous mecamylamine or dihydro-beta-erythroidine, two nicotinic acetylcholine receptor antagonists, resulted in significant dose-dependent reductions in nicotine self-administration, at two nicotine doses (0.03 and 0.06 mg/kg/inf). These results indicate that nicotine is an effective reinforcer in Wistar rats under the present parameters, and that these reinforcing effects are mediated by activation of nicotinic acetylcholine receptors.

PubMedSearch : Watkins_1999_Pharmacol.Biochem.Behav_62_743
PubMedID: 10208381

Related information

Citations formats

Watkins SS, Epping-Jordan MP, Koob GF, Markou A (1999)
Blockade of nicotine self-administration with nicotinic antagonists in rats
Pharmacol Biochem Behav 62 :743

Watkins SS, Epping-Jordan MP, Koob GF, Markou A (1999)
Pharmacol Biochem Behav 62 :743